α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock

Critical Care Medicine

Volumn 29, Issue 1, 2001, Pages 80-87

  Hartemink, Koen J ^a   Groeneveld, A B Johan ^a   De Groot, Marcel C M ^a   Strack Van Schijndel, Rob J M ^a   Van Kamp, Gerard ^a   Thijs, Lambertus G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cyclic guanosine monophosphate; Endothelin; Marker; Myocardial depression; Prognostic value; Septic shock; atrial natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; CYCLIC GMP; ENDOTHELIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART INDEX; HEART MUSCLE INJURY; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK;

EID: 0035146371     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200101000-00019     Document Type: Article

References (39)

1. Hemodynamic determinants of mortality in human septic shock
2. Hemodynamic response to fluid repletion in patients with septic shock: Evidence for early depression of cardiac performance
3. Accuracy in early prediction of prognosis of patients with septic shock by analysis of simple indices: Prospective study
4. Myocardial depression characterizes the fatal course of septic shock
5. Early hemodynamic course of septic shock
6. Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats
7. 2+ in cardiac myocytes
8. Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study
9. The cardiovascular response of normal humans to the administration of endotoxin
10. Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock
11. Methylene blue increases myocardial function in septic shock
12. Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock
13. Plasma concentration of alpha-human ANP and cyclic GMP in patients with heart disease
14. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac disease
15. Localization and mechanisms of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
16. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
17. Measurement and significance of circulating natriuretic peptides in cardio-vascular disease
18. Determinants of atrial natriuretic peptide in the adult respiratory distress syndrome
19. Plasma alpha-human atrial natriuretic peptide concentration in patients with acute lung injury
20. Endothelin-I and atrial natriuretic peptide in septic shock
21. Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide
22. Plasma α-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study
23. Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia
24. The atrial natriuretic peptide receptor antagonist HS 142-1 improves cardiovascular filling and mean arterial pressure in a hyperdynamic ovine model of sepsis
25. Mechanical ventilation with positive end-expiratory pressure decreases the circulating concentrations of the N-terminus and C-terminus of the atrial natriuretic factor prohormone
26. Endothelin-1 in adult respiratory distress syndrome
27. Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humans
28. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis
29. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock
30. Endothelin in human congestive heart failure
31. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure
32. APACHE II: A severity of disease classification system
33. An expanded definition of the adult respiratory distress syndrome
34. The use of relative operating characteristic (ROC) curves in test performance evaluation
35. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure
36. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart
37. 2+ infusion and aortic constriction in pigs
38. cGMP and atrial natriuretic factor regulate cell volume of rabbit atrial myocytes
39. Effect of endotoxin on circulating cyclic GMP in the rat